STOCK TITAN

Forbright (FRBT) EVP and CLO Ogrosky reports equity and option holdings

(Neutral)
(Neutral)
Form Type
3

Rhea-AI Filing Summary

Forbright, Inc. executive vice president and chief legal officer Kori Ogrosky filed an initial Form 3 reporting current equity holdings in the company. Ogrosky directly holds 83,793 shares of Class A common stock, including multiple restricted stock awards that vest over three- and five-year schedules.

Ogrosky also holds several stock option grants to buy Class A common stock at exercise prices between $12.36 and $17.04 per share, with expiration dates in 2031 and 2032. Some of these options and restricted awards are subject to performance-based vesting conditions tied to pre-established stock price hurdles.

Positive

  • None.

Negative

  • None.
Insider Ogrosky Kori
Role EVP and CLO
Type Security Shares Price Value
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Stock Option (right to buy) -- -- --
holding Class A Common Stock -- -- --
Holdings After Transaction: Stock Option (right to buy) — 170,000 shares (Direct); Class A Common Stock — 83,793 shares (Direct)
Footnotes (5)
  1. F1. Includes (i) 25,130 restricted stock awards ("RSAs") granted on March 13, 2025 that vest in five substantially equal annual installments on the first five anniversaries of the grant date; (ii) 13,500 RSAs granted on March 12, 2026 that vest in three substantially equal annual installments on the first three anniversaries of the grant date; and (iii) 46,875 RSAs granted on April 29, 2026 that vest in three substantially equal annual installments on the first three anniversaries of the grant date.
  2. F2. These options were granted on July 1, 2021 and vest in five equal annual installments on the first five anniversaries of the grant date, of which 20,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles.
  3. F3. These options were granted on July 1, 2021 and vest in five equal annual installments on the first five anniversaries of the grant date.
  4. F4. These options were granted on February 16, 2022 and vest in five equal annual installments on the first five anniversaries of the grant date, of which 17,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles.
  5. F5. These options were granted on February 16, 2022 and vest in five equal annual installments on the first five anniversaries of the grant date.
Direct Class A shares 83,793 shares Total Class A common stock held directly following reported holdings
RSA grant 1 25,130 shares Restricted stock awards granted March 13, 2025, vesting over five years
RSA grant 2 13,500 shares Restricted stock awards granted March 12, 2026, vesting over three years
RSA grant 3 46,875 shares Restricted stock awards granted April 29, 2026, vesting over three years
Option tranche 1 33,000 underlying shares at $17.04 Stock options expiring February 16, 2032, direct ownership
Option tranche 2 17,000 underlying shares at $13.50 Stock options expiring February 16, 2032, direct ownership
Option tranche 3 55,000 underlying shares at $17.04 Stock options expiring July 1, 2031, direct ownership
Option tranche 4 65,000 underlying shares at $12.36 Stock options expiring July 1, 2031, direct ownership
restricted stock awards financial
"Includes (i) 25,130 restricted stock awards ("RSAs") granted on March 13, 2025 that vest in five substantially equal annual installments..."
Restricted stock awards are company shares given to employees or executives that cannot be sold or transferred until certain conditions — like staying with the company for a set time or meeting performance targets — are met, like a gift that is locked in a safe until rules are satisfied. Investors care because these awards tie management’s pay to company performance, can increase the number of shares outstanding when they become tradable (dilution), and may signal expected future selling pressure or commitment to long-term growth.
Stock Option (right to buy) financial
"security_title": "Stock Option (right to buy)""
performance-based vesting conditions financial
"of which 20,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles."
pre-established stock price hurdles financial
"subject to performance-based vesting conditions based on pre-established stock price hurdles."
beneficial ownership financial
"initial statement of beneficial ownership of securities"
Beneficial ownership means the person or entity that actually enjoys the benefits of owning shares or other assets — such as receiving dividends, voting rights, or price gains — even if the legal title is held in another name. For investors it matters because knowing who truly controls and profits from a company reveals who can influence decisions, exposes potential conflicts of interest or hidden concentration of power, and affects transparency and risk in the stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google
Add on Google
Learn about SEC filing dates

FAQ

What did Forbright (FRBT) executive Kori Ogrosky report on the Form 3 filing?

Kori Ogrosky reported existing holdings of Forbright Class A common stock and stock options. The filing lists 83,793 directly held shares plus multiple restricted stock awards and several option grants with exercise prices between $12.36 and $17.04, expiring in 2031 and 2032.

How many Forbright (FRBT) common shares does Kori Ogrosky hold directly?

Kori Ogrosky holds 83,793 shares of Forbright Class A common stock directly. This position includes several restricted stock awards that vest over multi-year periods, reflecting a mix of time-based and performance-based equity compensation tied to future service and stock price hurdles.

What restricted stock awards are disclosed for Kori Ogrosky in Forbright’s Form 3?

The Form 3 notes restricted stock awards granted on March 13, 2025, March 12, 2026, and April 29, 2026. These RSAs vest in substantially equal annual installments over three or five years, aligning Ogrosky’s equity compensation with long-term employment and company performance.

What stock option grants for Forbright (FRBT) shares does Kori Ogrosky report?

Ogrosky reports several stock option grants to buy Forbright Class A common stock. These include options with exercise prices of $17.04, $13.50, and $12.36 per share, with expiration dates in 2031 and 2032, providing long-dated potential ownership if vesting conditions are satisfied.

Are any of Kori Ogrosky’s Forbright equity awards performance-based?

Yes. The footnotes state that portions of the July 1, 2021 and February 16, 2022 option grants are subject to performance-based vesting. Vesting depends on meeting pre-established stock price hurdles, tying part of Ogrosky’s potential equity gains directly to Forbright’s market performance.

Does the Forbright Form 3 for Kori Ogrosky show any recent share purchases or sales?

The Form 3 functions as an initial statement of beneficial ownership and only reports holdings. The summarized data classify all entries as holdings with unknown transaction codes, and there are no recorded buy or sell transactions in the transaction summary for this filing.
SEC Form 3
FORM 3UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940
OMB APPROVAL
OMB Number:3235-0104
Estimated average burden
hours per response:0.5
1. Name and Address of Reporting Person*
Ogrosky Kori

(Last)(First)(Middle)
4445 WILLARD AVENUE
SUITE 1000

(Street)
CHEVY CHASE MARYLAND 20815

(City)(State)(Zip)

UNITED STATES

(Country)
2. Date of Event Requiring Statement (Month/Day/Year)
06/10/2026
3. Issuer Name and Ticker or Trading Symbol
Forbright, Inc. [ FRBT ]
3a. Foreign Trading Symbol
5. If Amendment, Date of Original Filed (Month/Day/Year)
4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
Director10% Owner
XOfficer (give title below)Other (specify below)
EVP and CLO
6. Individual or Joint/Group Filing (Check Applicable Line)
XForm filed by One Reporting Person
Form filed by More than One Reporting Person
Table I - Non-Derivative Securities Beneficially Owned
1. Title of Security (Instr. 4) 2. Amount of Securities Beneficially Owned (Instr. 4) 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 4. Nature of Indirect Beneficial Ownership (Instr. 5)
Class A Common Stock83,793(1)D
Table II - Derivative Securities Beneficially Owned
(e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 4) 2. Date Exercisable and Expiration Date (Month/Day/Year)3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) 4. Conversion or Exercise Price of Derivative Security 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) 6. Nature of Indirect Beneficial Ownership (Instr. 5)
Date ExercisableExpiration DateTitleAmount or Number of Shares
Stock Option (right to buy) (2)07/01/2031Class A Common Stock65,000$12.36D
Stock Option (right to buy) (3)07/01/2031Class A Common Stock55,000$17.04D
Stock Option (right to buy) (4)02/16/2032Class A Common Stock17,000$13.5D
Stock Option (right to buy) (5)02/16/2032Class A Common Stock33,000$17.04D
Explanation of Responses:
1. Includes (i) 25,130 restricted stock awards ("RSAs") granted on March 13, 2025 that vest in five substantially equal annual installments on the first five anniversaries of the grant date; (ii) 13,500 RSAs granted on March 12, 2026 that vest in three substantially equal annual installments on the first three anniversaries of the grant date; and (iii) 46,875 RSAs granted on April 29, 2026 that vest in three substantially equal annual installments on the first three anniversaries of the grant date.
2. These options were granted on July 1, 2021 and vest in five equal annual installments on the first five anniversaries of the grant date, of which 20,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles.
3. These options were granted on July 1, 2021 and vest in five equal annual installments on the first five anniversaries of the grant date.
4. These options were granted on February 16, 2022 and vest in five equal annual installments on the first five anniversaries of the grant date, of which 17,000 options are also subject to performance-based vesting conditions based on pre-established stock price hurdles.
5. These options were granted on February 16, 2022 and vest in five equal annual installments on the first five anniversaries of the grant date.
Remarks:
Exhibit 24.1 - Power of Attorney
/s/ Kori L. Ogrosky06/10/2026
** Signature of Reporting PersonDate
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.
* Form 3: SEC 1473 (03-26)